EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

PD ‐1 expressing islet‐specific CD4 + T cells promote bystander tolerance and prevent autoimmunity

Jeniffer D Loaiza Naranjo, Vivian Zhang, Rathna Ravichandran, Anne-Sophie Bergot, Ranjeny Thomas iD, Emma E Hamilton-Williams iD

Immunology & Cell Biology · 2025

DOI: 10.1111/imcb.70044 ↗

At a glance

Journal article in Immunology & Cell Biology, 2025. Written by Jeniffer D Loaiza Naranjo and 5 co-authors. Institution: Frazer Institute, The University of Queensland, Brisbane, QLD, Australia. Major MEDLINE topics: Programmed Cell Death 1 Receptor, CD4-Positive T-Lymphocytes, Islets of Langerhans, Autoimmunity. 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Health and Medical Research Council, Diabetes Australia.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Loss of T‐cell tolerance to multiple islet antigens is a key feature of autoimmune type 1 diabetes. In this study, we investigated the requirement for programmed death 1 (PD‐1) expression by CD4 + T cells in the maintenance of self‐tolerance via bystander suppression of autoreactive CD8 + T cells using nonobese diabetic mice. We used CRISPR/Cas9 to selectively knockout PD‐1 in islet antigen‐specific BDC2.5 CD4 + T cells and observed the impact on bystander tolerance of 8.3 CD8 + T cells, specific for a different islet antigen. Loss of PD‐1 promoted the proliferation, Th1‐like effector‐memory phenotype, islet infiltration and expression of cytotoxic markers by BDC2.5 cells. PD‐1‐deficient BDC2.5 cells were impaired in their regulation of 8.3 cells, which proliferated more, developed an effector‐memory phenotype and increased expression of effector molecules. While antigen‐presenting cell maturation and migration into the pancreatic lymph node were not impacted by loss of PD‐1 expression from BDC2.5 cells, migration of BDC2.5 cells out of the lymph node was required for enhanced activation of the CD8 + T cells. Together, these events led to accelerated diabetes progression, suggesting that PD‐1 expression by CD4 + T cells promotes a tolerogenic microenvironment and restraining autoreactive CD8 + T cells.

Subjects

MeSH terms (MEDLINE)

Programmed Cell Death 1 ReceptorCD4-Positive T-LymphocytesIslets of LangerhansAutoimmunityBystander EffectImmune ToleranceAnimalsMiceCD8-Positive T-LymphocytesMice, Inbred NODDiabetes Mellitus, Type 1Immunologic MemoryMice, Knockout

Author keywords

PD‐1autoimmunityregulationtolerancetype 1 diabetes

Substances

Programmed Cell Death 1 ReceptorPdcd1 protein, mouse

Authors and institutions

  • Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.

ORCID profiles: Ranjeny Thomas, Emma E Hamilton-Williams

Funding

  • National Health and Medical Research Council
  • Diabetes Australia

Cite

APA

Loaiza Naranjo, J. D., Zhang, V., Ravichandran, R., Bergot, A. S., Thomas, R., & Hamilton-Williams, E. E. (2025). PD ‐1 expressing islet‐specific CD4 + T cells promote bystander tolerance and prevent autoimmunity. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70044

Vancouver

Loaiza Naranjo JD, Zhang V, Ravichandran R, Bergot AS, Thomas R, Hamilton-Williams EE. PD ‐1 expressing islet‐specific CD4 + T cells promote bystander tolerance and prevent autoimmunity. Immunology & Cell Biology. 2025. doi:10.1111/imcb.70044

BibTeX
@article{LoaizaNaranjo2025,
  author = {Loaiza Naranjo, Jeniffer D and Zhang, Vivian and Ravichandran, Rathna and Bergot, Anne-Sophie and Thomas, Ranjeny and Hamilton-Williams, Emma E},
  title = {PD ‐1 expressing islet‐specific CD4 + T cells promote bystander tolerance and prevent autoimmunity},
  journal = {Immunology & Cell Biology},
  year = {2025},
  doi = {10.1111/imcb.70044}
}
Start for free →